Mr. Konagai is a Senior Investment Manager and joined AVM in 2020. Before joining AVM, he worked at the Strategic department at Astellas Pharma Inc. based in Tokyo HQ since 2015. He has led various internal projects and evaluation of external later stage opportunities across multiple therapeutic areas and modalities including Oncology, Ophthalmology, and regenerative medicine. In parallel, he served as a member who develops corporate global R&D strategy and business strategy for regenerative medicine using his scientific and business intelligence. From 2004 to 2015, he was engaged in Oncology research programs including kinase inhibitors, Immuno-Oncology and biologics from target discovery to clinical stage as a pharmacology research scientist in the Drug Discovery Research Center at Astellas Pharma Inc. Mr. Konagai received his Master of Life Science degree in the field of Integrated Life Science from Kyoto University and Master of Business Administration, Entrepreneurship and Innovation from University of Massachusetts Lowell.
